H.R. 8630 · 119th Congress (2025–2027)
PEAT Act of 2026
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 8630’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Michael A. Rulli (R-OH-6)
- Cosponsors
12 cosponsors
1 original · 11 later
11 R · 1 D
- Rep. Diana Harshbarger (R-TN-1)· Original · Apr 30, 2026
- Rep. Morgan Luttrell (R-TX-8)· Later · May 13, 2026
- Rep. Brian Babin (R-TX-36)· Later · May 14, 2026
- Rep. Mike Kennedy (R-UT-3)· Later · May 15, 2026
- Rep. John R. Carter (R-TX-31)· Later · Jun 2, 2026
- Rep. Abraham J. Hamadeh (R-AZ-8)· Later · Jun 8, 2026
- Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Jun 23, 2026
- Rep. Troy E. Nehls (R-TX-22)· Later · Jun 24, 2026
- Rep. Michael T. McCaul (R-TX-10)· Later · Jun 29, 2026
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Jul 16, 2026
- Rep. Ro Khanna (D-CA-17)· Later · Jul 20, 2026
- Rep. Nicholas A. Langworthy (R-NY-23)· Later · Aug 13, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
PEAT Act of 2026
Display title, Short title · Introduced in House
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Official title · Introduced in House
Protecting Equal Access to Thyroid Act of 2026
Short title · Introduced in House